» Articles » PMID: 34259194

Clinical Profile of Hospitalized COVID-19 Patients in First & Second Wave of the Pandemic: Insights from an Indian Registry Based Observational Study

Overview
Specialty General Medicine
Date 2021 Jul 14
PMID 34259194
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Objectives: India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves.

Methods: The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demographic, clinical, treatment and outcome data of hospitalized, confirmed COVID-19 patients were captured in an electronic data portal from 41 hospitals across India. Patients enrolled during September 1, 2020 to January 31, 2021 and February 1 to May 11, 2021 constituted participants of the two successive waves, respectively.

Results: As on May 11, 2021, 18961 individuals were recruited in the registry, 12059 and 6903 reflecting in-patients from the first and second waves, respectively. Mean age of the patients was significantly lower in the second wave [48.7 (18.1) yr vs. 50.7 (18.0) yr, P<0.001] with higher proportion of patients in the younger age group intervals of <20, and 20-39 yr. Approximately 70 per cent of the admitted patients were ≥ 40 yr of age in both waves of the pandemic. The proportion of males were slightly lower in second wave as compared to the first [4400 (63.7%) vs. 7886 (65.4%), P=0.02]. Commonest presenting symptom was fever in both waves. In the second wave, a significantly higher proportion [2625 (48.6%) vs. 4420 (42.8%), P<0.003] complained of shortness of breath, developed ARDS [422(13%) vs. 880 (7.9%), P<0.001], required supplemental oxygen [1637 (50.3%) vs. 4771 (42.7%), P<0.001], and mechanical ventilation [260 (15.9%) vs. 530 (11.1%), P<0.001]. Mortality also significantly increased in the second wave [OR: 1.35 (95% CI: 1.19, 1.52)] in all age groups except in <20 yr.

Interpretation & Conclusions: The second wave of COVID-19 in India was slightly different in presentation than the first wave, with a younger demography, lesser comorbidities, and presentation with breathlessness in greater frequency.

Citing Articles

Prediction of mortality and prioritisation to tertiary care using the 'OUR-ARCad' risk score gleaned from the second wave of COVID-19 pandemic-A retrospective cohort study from South India.

Gopalan N, Viswanathan V, Srinivasalu V, Arumugam S, Bhaskar A, Manoharan T PLoS One. 2025; 20(1):e0312993.

PMID: 39854588 PMC: 11761102. DOI: 10.1371/journal.pone.0312993.


Difference in the epidemiological and clinical profiles of mortality between the first and second waves of COVID-19 pandemic in a tertiary care hospital of Andaman and Nicobar Islands.

Roy A, Jahnavi G, Peter S, Dakuya T, Venugopal V, Bhattacharya S J Educ Health Promot. 2025; 13():433.

PMID: 39811844 PMC: 11731239. DOI: 10.4103/jehp.jehp_1887_23.


Assessment of COVID-19 patients' outcome based on clinical profile, laboratory parameters, and clinical management: A retrospective observational study.

Khullar S, Kothari V, Kothari R, Lakhotia M J Family Med Prim Care. 2024; 13(10):4678-4683.

PMID: 39629435 PMC: 11610858. DOI: 10.4103/jfmpc.jfmpc_787_24.


Shift in Demographic Involvement and Clinical Characteristics of COVID-19 From Wild-Type SARS-CoV-2 to the Delta Variant in the Indian Population: In Silico Analysis.

Kumar A, Asghar A, Raza K, Narayan R, Jha R, Satyam A Interact J Med Res. 2024; 13:e44492.

PMID: 39378428 PMC: 11496911. DOI: 10.2196/44492.


Analyzing the Outcomes of COVID-19 Infection on Patients With Comorbidities: Insights From Hospital-Based Study.

Bakthavatchalam R, Bakthavatchalam S, Ravikoti S, Shanmukham B, Reddy K, Pallavali J Cureus. 2024; 16(3):e55358.

PMID: 38562329 PMC: 10982082. DOI: 10.7759/cureus.55358.


References
1.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

2.
Jalali S, Ghassemzadeh M, Mouodi S, Javanian M, Akbari Kani M, Ghadimi R . Epidemiologic comparison of the first and second waves of coronavirus disease in Babol, North of Iran. Caspian J Intern Med. 2021; 11(Suppl 1):544-550. PMC: 7780865. DOI: 10.22088/cjim.11.0.544. View

3.
Elshazli R, Kline A, Elgaml A, Aboutaleb M, Salim M, Omar M . Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves. J Med Virol. 2021; 93(5):2740-2768. PMC: 8014082. DOI: 10.1002/jmv.26836. View

4.
Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H . First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J Infect. 2020; 82(4):84-123. PMC: 7605825. DOI: 10.1016/j.jinf.2020.10.033. View

5.
Tobin M, Laghi F, Jubran A . Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med. 2020; 202(3):356-360. PMC: 7397783. DOI: 10.1164/rccm.202006-2157CP. View